miRNA 0-h (125mg). 3-h (125mg). 0-h (500mg). 6-h (500mg).
    Percentages Percentages Percentages Percentages
A Inflammation        
1 miR-9 100 88 100 44
2 miR-34a 100 72 100 59
3 miR-107 100 156 100 173
4 miR122a 100 166 100 196
5 miR-132 100 199 100 145
6 miR-148a 100 208 100 233
7 miR-181a 100 48 100 21
B Cardiovascular        
8 miR-24 100 77 100 45
9 miR-19b 100 91 100 70
C Cancer        
10 miR-1 100 78 100 63
11 miR-7 100 94 100 85
12 miR-15b 100 110 100 132
13 miR-17-5p 100 106 100 168
14 miR-19a 100 95 100 36
15 miR-26a 100 80 100 62
16 miR-106a 100 74 100 56
17 miR-143 100 63 100 36
18 miR-145 100 54 100 44
19 miR-182 100 76 100 64
20 miR-192 100 28 100 21
21 miR-194 100 50 100 21
22 miR-196a 100 65 100 43
23 miR-199a 100 81 100 65
24 miR-204 100 45 100 41
25 miR-205 100 39 100 45
26 miR-222 100 55 100 51
27 miR-342 100 70 100 52
Table 7: Plasma miRNAs of d-tocotrienol at 0h-3h (125 mg) and 0h-6h (500 mg) of pharmacokinetic study in humans.